Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004480
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-10-18
Brief Title:
Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Office of Rare Diseases ORD
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2004-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES
I Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis
I Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis
Detailed Description:
PROTOCOL OUTLINE
Patients receive injections of botulinum toxin in the clinical trial for 6 months Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug Patients also complete questionnaires to evaluate the amount of sweating
Patients receive injections of botulinum toxin in the clinical trial for 6 months Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug Patients also complete questionnaires to evaluate the amount of sweating
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MTS-GCO-98-913NE | None | None | None |
| ALLERGAN-MTS-GCO-98-913NE | None | None | None |